Development of Drug-Eluting Stent Coated With PLGA Nanoparticles as Drug Carriers

KONA Powder and Particle Journal - Japan
doi 10.14356/kona.2013004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hosokawa Powder Technology Foundation

Related search

Drug-Eluting Stent Restenosis Rates?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Development of Polymeric Coating Material for Effective Drug-Eluting Stent

Polymer (Korea)
PolymersMaterials ChemistryPlasticsChemical Engineering
2011English

Biocompatible Superparamagnetic Nanoparticles With Ibuprofen as Potential Drug Carriers

SN Applied Sciences
2020English

Two-Month Angioscopic Evaluation of Superficial Femoral Artery Treated With Paclitaxel-Coated Nitinol Drug-Eluting Stent

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Antiplatelet Therapy After Drug-Eluting Stent Implantation

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Angiographic Patterns of Restenosis With 2nd Generation Drug-Eluting Stent

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

Characteristics and Predictors of Drug-Eluting Stent Thrombosis

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Continuous Development of Neoatherosclerosis Beyond a Decade After Drug-Eluting Stent Implantation

EuroIntervention
MedicineCardiovascular MedicineCardiology
2018English

Network Meta-Analysis of Balloon Angioplasty, Nondrug Metal Stent, Drug-Eluting Balloon, and Drug-Eluting Stent for Treatment of Infrapopliteal Artery Occlusive Disease

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy